Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...

People hit by the virus can suffer from severe nausea and vomiting, watery diarrhoea leading to dehydration, painful stomach cramps, and possible low-grade fevers, chills, muscle aches, and tiredness, ...

The latest NHS figures show twice as many cases as last year and more than 1,000 people a day in the hospital with norovirus ...

The FDA approved omalizumab-igec (Omlyclo) as the first biosimilar for omalizumab (Xolair) and the first for any respiratory ...

Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have discovered a ...

The outbreak of gastroenteritis on an epidemic scale has been recorded in Khyber-Pakhtunkhwa (K-P), with 19,534 cases ...

Dr Ray O’Connor takes a look at some of the most recent clinical studies on irritable bowel syndrome (IBS) ...

Kolkata: Travel restrictions triggered by tension at the India-Bangladesh border and a consequent drop in patients from the ...

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of ...

The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies for the treatment of norovirus-associated gastroenteritis.

In January alone, health officials reported 40 cases of the bacterial disease, which is characterized by severe diarrhoea.

In the United States, noroviruses are the single most common cause of acute gastroenteritis in adults that results in a visit to the hospital emergency department, and they are second only to ...